Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-24

FDA Approved: FINGOLIMOD — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Fingolimod from Aurobindo Pharma Limited, authorizing a generic version of the MS therapy Fingolimod.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fingolimod (fingolimod)

Snippet

SUPPL AP for FINGOLIMOD (FINGOLIMOD)